Literature DB >> 8306259

Production of no-carrier-added 64Cu from zinc metal irradiated under boron shielding.

K R Zinn1, T R Chaudhuri, T P Cheng, J S Morris, W A Meyer.   

Abstract

BACKGROUND: Positron emission tomography offers advantages for radioimmunodiagnosis of cancer but requires radionuclides of appropriate half-life that have high specific activity and high radio-purity. This work was designed to develop a viable method to produce and purify 64Cu, which has high specific activity, for positron emission tomography.
METHODS: 64Cu was produced at the University of Missouri Research Reactor by the nuclear reaction, 64Zn(n,p)64Cu. Highly pure zinc metal (99.9999%) was irradiated in a specially designed boron nitrite lined container, which minimized thermal neutron reactions during irradiation. A new two-step procedure was developed to chemically separate the no-carrier-added 64Cu from the zinc metal target.
RESULTS: 64Cu recovery for 24 runs averaged 0.393 (+/- 0.007) mCi per milligram of zinc irradiated. The boron-lined irradiation container reduced unwanted zinc radionuclides 14.3-fold. Zinc radionuclides and non-radioactive zinc were separated successfully from the 64Cu. The new separation technique was fast (2 hours total time) and highly efficient for removing the zinc. The zinc separation factor for this technique averaged 8.5 x 10(-8), indicating less than 0.0000085% of the zinc remained after separation. Thus far, the highest 64Cu specific activity at end of irradiation was 683 Ci/mg Cu, with an average of 512 Ci/mg Cu for the last six analyzed runs.
CONCLUSION: The boron-lined irradiation container has sufficient capacity for 75-fold larger-sized zinc targets (up to 45 g). The new separation technique was excellent for separating 64Cu, which appears to be a radionuclide with great potential for positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306259     DOI: 10.1002/1097-0142(19940201)73:3+<774::aid-cncr2820731305>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.

Authors:  J M Connett; C J Anderson; L W Guo; S W Schwarz; K R Zinn; B E Rogers; B A Siegel; G W Philpott; M J Welch
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  A comparison of PET imaging characteristics of various copper radioisotopes.

Authors:  Heather Ann Williams; Simon Robinson; Peter Julyan; Jamal Zweit; David Hastings
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-29       Impact factor: 9.236

Review 3.  Porphyrins as ligands for 64copper: background and trends.

Authors:  Edgar Aguilar-Ortíz; Amir R Jalilian; Miguel A Ávila-Rodríguez
Journal:  Medchemcomm       Date:  2018-08-17       Impact factor: 3.597

Review 4.  Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer.

Authors:  Xianwen Hu; Dandan Li; Yujie Fu; Jiashen Zheng; Zelong Feng; Jiong Cai; Pan Wang
Journal:  Front Oncol       Date:  2022-06-15       Impact factor: 5.738

5.  Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).

Authors:  Monica Shokeen; Carolyn J Anderson
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

Review 6.  Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.

Authors:  Tapan K Nayak; Martin W Brechbiel
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

Review 7.  Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging.

Authors:  C J Anderson; T J Wadas; E H Wong; G R Weisman
Journal:  Q J Nucl Med Mol Imaging       Date:  2007-11-28       Impact factor: 2.346

Review 8.  Iron Oxide Nanoradiomaterials: Combining Nanoscale Properties with Radioisotopes for Enhanced Molecular Imaging.

Authors:  Juan Pellico; Jordi Llop; Irene Fernández-Barahona; Riju Bhavesh; Jesús Ruiz-Cabello; Fernando Herranz
Journal:  Contrast Media Mol Imaging       Date:  2017-11-21       Impact factor: 3.161

Review 9.  Somatostatin analogues labeled with copper radioisotopes: current status.

Authors:  Aleksandra Marciniak; Justyna Brasuń
Journal:  J Radioanal Nucl Chem       Date:  2017-06-13       Impact factor: 1.371

Review 10.  The copper radioisotopes: a systematic review with special interest to 64Cu.

Authors:  Artor Niccoli Asabella; Giuseppe Lucio Cascini; Corinna Altini; Domenico Paparella; Antonio Notaristefano; Giuseppe Rubini
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.